Pharmacists’ and patients’ views and feedback on Italian Medicines Use Review (I-MUR)
Abstract
Rationale, aims and objectives: Although medicine review services are offered by community pharmacists in many countries, they are non-existent in Italy. A novel intervention, I-MUR, was developed for patients with asthma aiming to improve medicines use. The aim of this study was to obtain pharmacists’ and patients’ views on the acceptability of the I-MUR service provided by community pharmacists to asthma patients in 4 Italian regions.
Methods: Pharmacists’ expectations, experiences and attitudes to delivering the I-MUR were obtained through questionnaires distributed before and after delivering the I-MUR, plus focus groups. Patients’ views were obtained via questionnaires, distributed by the pharmacists and returned anonymously.
Results: Seventy-four pharmacists provided the I-MUR service to 895 asthma patients; 49 pharmacists completed both questionnaires, 53 participated in focus groups and 246 patients returned questionnaires. Barriers anticipated most frequently by pharmacists before the I-MUR were lack of time (53%) and lack of co-ordination with other health professionals (61%), while lack of financial compensation was identified by 37%. Lack of co-ordination proved the most common actual barrier (88%), with lack of financial compensation being cited less frequently after providing the intervention (8%). Ninety-six percent of pharmacists anticipated providing both education on inhaler technique and medication counselling, but in practice slightly fewer had provided these (90% and 86% respectively). Focus groups highlighted a lack of relevant undergraduate education to support medication review and structural barriers within some pharmacies, but described positive patient feedback and a desire to extend the I-MUR. Patient respondents were positive; 62% indicated the reason for having an I-MUR as making sure that they were using medication correctly, 75% considered they benefited from it and 86% would recommend it to others.
Conclusions: The I-MUR service was perceived positively by both pharmacists and patients, supporting the extension of medicine review services to community pharmacists in Italy in an enhancement of the person-centeredness of care.Keywords
Full Text:
PDFReferences
Todd, A., Copeland, A., Husband, A., Kasim, A. & Bambra, C. (2014). The positive pharmacy care law: an area-level analysis of the relationship between community pharmacy distribution, urbanity and social deprivation in England. BMJ Open 4, e005764.
British Medical Association (BMA). (2016). Funding for community pharmacies. Available from: http://bma.org.uk/practical-support-at-work/gp-practices/service-provision/prescribing/the-community-pharmacy/nhs-community-pharmacy-contractual-framework. Accessed September 14, 2017.
Petty, D.R., Knapp, P., Raynor, D.K. & House, A.O. (2003). Patients' views of a pharmacist-run medication review clinic in general practice. British Journal of General Practice 53 (493) 607-613.
Tinelli, M., Bond, C., Blenkinsopp, A., Jaffray, M., Watson, M., Hannaford, P. & On the behalf of the Community Pharmacy Medicines Management Evaluation Team. (2007). Patients’ evaluation of a community pharmacy medications management service. Annals of Pharmacotherapy 41, 1962-1970.
Bissel, P., Blenkinsopp, A., Short, D. & Manson, L. (2008). Patients' experiences of a community pharmacy-led medicines management service. Health & Social Care in the Community 16 (4) 363-369.
Latif, A., Boardman, H.F. & Pollock, K. (2013). Understanding the patient perspective of the English community pharmacy Medicines Use Review (MUR). Research in Social and Administrative Pharmacy 9 (6) 949-957.
Worley, M.M., Schommer, J.C., Brown, L.M., Hadsall, R.S., Ranelli, P.L. Stratton, T.P. & Uden, D.L. (2007). Pharmacists' and patients' roles in the pharmacist-patient relationship: are pharmacists and patients reading from the same relationship script? Research in Social and Administrative Pharmacy 3 (1) 47-69.
Assa-Eley, M. & Kimberlin, C.L. (2005). Using interpersonal perception to characterize pharmacists' and patients' perceptions of the benefits of pharmaceutical care. Health Communication 17 (1) 41-56.
Puspitassari, H.P., Aslani, P. & Krass, I. (2010). Pharmacists’ and consumers’ viewpoints on counselling on prescription medicines in Australian community pharmacies. International Journal of Pharmacy Practice 18 (4) 202-208.
Rodgers, R.M., Gammie, S.M., Loo, R.L., Corlett, S.A. & Krska, J. (2016). Comparison of pharmacist and public views and experiences of community pharmacy medicines-related services in England. Patient Preference and Adherence 10, 1749-1758.
Manfrin, A., Thomas, T. & Krska, J. (2015). Randomised evaluation of the Italian medicines use review provided by community pharmacists using asthma as a model (RE I-MUR). BMC Health Services Research 15, 171.
Jaffray, M., Krska, J., Lee, J. & Bond, C.M. (2007). The MEDMAN project: evaluation of the medicines management training for community pharmacists. Pharmacy Education 7 (3) 207-214.
Krska, J., Jamieson, D., Arris, F., McGuire, A., Abbott, S., Hansford, D. & Cromarty, J. (2002). A classification system for issues identified in pharmaceutical care practice. International Journal of Pharmacy Practice 10 (2) 91-100.
Krska, J., Nesbit, J., Baylie, K. & O’Kane, A. (2009). Patient views on the MUR service. International Journal of Pharmacy Practice 17 (Supplement 1) A40-A42.
Youssef, S., Hussain, S. & Upton, D. (2010). Do patients perceive any benefits from medicines use reviews offered to them in community pharmacies? Pharmaceutical Journal 184, 165-166.
Kaulbach, M., Lowe, C., Petty, D. & Rao, S. (2010). MUR support and evaluation programme Report, National Pharmacy Association and Primary Care Pharmacists Association.
Bradley, F., Wagner, A.C., Elvey, R., Noyce, P.R. & Ashcroft, D.M. (2008). Determinants of the uptake of medicines use reviews (MURs) by community pharmacies in England: a multi-method study. Health Policy 88 (2-3) 258-268.
Latif, A., Pollock, K. & Boardman, H.F. (2013). Medicines use reviews: a potential resource or lost opportunity for general practice? BMC Family Practice 14, 57.
Lee, E., Braund, R. & Tordoff, J. (2009). Examining the first year of Medicines Use Review services provided by pharmacists in New Zealand: 2008. New Zealand Medical Journal 122 (1293) 26-35.
Pharmaceutical Services Negotiating Committee. (2016). MUR premises requirements. Available from: http://psnc.org.uk/services-commissioning/advanced- services/murs/mur-premises-requirements/ Accessed September 14, 2016.
Saramunee, K., Krska, J., Mackridge, A., Richards, J., Suttajit, S. & Phillips-Howard, P. (2014). How to enhance public health service utilization in community pharmacy?: general public and health providers' perspectives. Research in Social & Administrative Pharmacy 10 (2) 272-284.
DOI: http://dx.doi.org/10.5750/ejpch.v6i2.1463
Refbacks
- There are currently no refbacks.